Neurology Central

Study identifies gene that could lead to new ALS therapies

Researchers from the Ben-Gurion University of the Negev (Beersheba, Israel) have identified a gene that is able to inhibit the accumulation of misfolded superoxide dismutase (SOD1) proteins in in vivo amyotrophic lateral sclerosis (ALS) mouse models. The researchers hope that their observations could lead to the development of new therapies for ALS.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.